Compare Repligen Corporation Common Stock (RGEN) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Verizon Communications Inc — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B), while Verizon Communications Inc trades at $44.84 (market cap $180.86B). The key difference: Verizon Communications Inc is far larger — about 16.2× Repligen Corporation Common Stock's market cap, and Verizon Communications Inc pays a 6.5% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Verizon Communications Inc for 109 Days on average.
| RGEN | VZ | |
|---|---|---|
Market Cap | $11.14B | $180.86B |
Volume | 1,259,263 | 30,427,702 |
Sector | Health | Media |
52-Week High | $194.57 | $51.45 |
52-Week Low | $102.87 | $38.40 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $11.02B | $367.56B |
Dividend Yield | — | 6.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Verizon (VZ) trades at $43.53, up 1.75% today, with a bearish technical signal despite recent earnings beats. The stock shows attractive valuation metrics including a P/E of 11.34 and dividend yield support, while maintaining strong cash flow generation of $37.14B from operations in 2025. Recent developments include a joint satellite venture with AT&T and T-Mobile announced October 1, 2026, and upcoming Q3 earnings on October 26, 2026.
VZ presents a value opportunity with solid fundamentals but faces technical headwinds. The company's consistent dividend payments and improving cash flow trends provide income stability, while competitive pressures in the telecom sector and high debt levels ($144B total debt) represent ongoing challenges. Analyst consensus targets $47.83 with 38% buy ratings, suggesting moderate upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
